✦ LIBER ✦

Influence of comorbidity, age and performance status on treatment efficacy and safety of cetuximab plus irinotecan in irinotecan-refractory elderly patients with metastatic colorectal cancer

✍ Scribed by Jehn, C.F.; Böning, L.; Kröning, H.; Pezzutto, A.; Lüftner, D.

Book ID: 122222386
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 416 KB
Volume: 50
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2014.01.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical usefulness ofKRAS,BRAF, andPIK3

Clinical usefulness ofKRAS,BRAF, andPIK3CAmutations as predictive markers of cetuximab efficacy in irinotecan- and oxaliplatin-refractory Japanese patients with metastatic colorectal cancer

✍ Soeda, Hiroshi; Shimodaira, Hideki; Watanabe, Mika; Suzuki, Takao; Gamoh, Makio; 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 402 KB

Safety and efficacy of second-line treat

Safety and efficacy of second-line treatment with folinic acid, 5-fluorouracil and irinotecan (FOLFIRI) in combination of panitumumab and bevacizumab for patients with metastatic colorectal cancer

✍ Xie, Song; Han, Guoping; Fan, Zhikun; He, Lifeng; Xu, Wenbing; Qin, Zhen 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 253 KB

Efficacy and safety of bevacizumab-based

Efficacy and safety of bevacizumab-based combination regimens in patients with previously untreated metastatic colorectal cancer: Final results from a randomised phase ii study of bevacizumab plus 5-fluorouracil, leucovorin plus irinotecan versus bevacizumab plus capecitabine plus irinotecan (FNCLCC ACCORD 13/0503 study)

✍ Ducreux, M.; Adenis, A.; Pignon, J.-P.; François, E.; Chauffert, B.; Ichanté, J. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 602 KB

3025 POSTER Impact of pre-medication on

3025 POSTER Impact of pre-medication on the frequency of infusion-related reactions (IRRs) and efficacy in patients (pts) treated with cetuximab plus irinotecan for metastatic colorectal cancer (mCRC): the MABEL study

✍ H. Wilke; S. Siena; J. Thaler; A. Adenis; P. Preusser; J. Bridgewater; G. Gaspar 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Comparing safety and efficacy of first-l

Comparing safety and efficacy of first-line irinotecan/fluoropyrimidine combinations in elderly versus nonelderly patients with metastatic colorectal cancer : Findings from the bolus, infusional, or capecitabine with camptostar-celecoxib study

✍ Nadine A. Jackson; José Barrueco; Raoudha Soufi-Mahjoubi; John Marshall; Edith M 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 344 KB 👁 1 views

385 A phase II trial to assess the effic

385 A phase II trial to assess the efficacy and safety of gefitinib (Iressa™) in patients with metastatic hormone refractory prostate cancer (HRPC) who progressed on treatment with a luteinising hormone releasing hormone analogue (or post orchiectomy) plus an antiandrogen

✍ G. Curigliano; O. De Cobelli; M.T. Sandri; L. Zorzino; C. Noberasco; T. De Pas; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 292 KB